Your browser doesn't support javascript.
loading
The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.
Van den Eynde, Vincent; Abdelmoemin, Wegdan R; Abraham, Magid M; Amsterdam, Jay D; Anderson, Ian M; Andrade, Chittaranjan; Baker, Glen B; Beekman, Aartjan T F; Berk, Michael; Birkenhäger, Tom K; Blackwell, Barry B; Blier, Pierre; Blom, Marc B J; Bodkin, Alexander J; Cattaneo, Carlo I; Dantz, Bezalel; Davidson, Jonathan; Dunlop, Boadie W; Estévez, Ryan F; Feinberg, Shalom S; Finberg, John P M; Fochtmann, Laura J; Gotlib, David; Holt, Andrew; Insel, Thomas R; Larsen, Jens K; Mago, Rajnish; Menkes, David B; Meyer, Jonathan M; Nutt, David J; Parker, Gordon; Rego, Mark D; Richelson, Elliott; Ruhé, Henricus G; Sáiz-Ruiz, Jerónimo; Stahl, Stephen M; Steele, Thomas; Thase, Michael E; Ulrich, Sven; van Balkom, Anton J L M; Vieta, Eduard; Whyte, Ian; Young, Allan H; Gillman, Peter K.
Afiliação
  • Van den Eynde V; PsychoTropical Research, QLD, Australia.
  • Abdelmoemin WR; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Abraham MM; Neurawell Therapeutics, Boca Raton, FL, USA.
  • Amsterdam JD; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Anderson IM; Department of Psychiatry, University of Manchester, Manchester, UK.
  • Andrade C; Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India.
  • Baker GB; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
  • Beekman ATF; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Berk M; Institute for Mental and Physical Health and Clinical Translation, Deakin University, Geelong, VIC, Australia.
  • Birkenhäger TK; Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Blackwell BB; Department of Psychiatry, University of Wisconsin, Milwaukee, WI, USA.
  • Blier P; Departments of Psychiatry and Cellular & Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Blom MBJ; Parnassia Groep, The Hague, The Netherlands.
  • Bodkin AJ; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Cattaneo CI; Brain Stimulation Italia, Cavaglietto, Italy.
  • Dantz B; Department of Psychiatry and Behavioral Sciences, Rush Medical College, Chicago, IL, USA.
  • Davidson J; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
  • Dunlop BW; Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, USA.
  • Estévez RF; College of Medicine, University of Central Florida, Orlando, FL, USA.
  • Feinberg SS; Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, NY, USA.
  • Finberg JPM; Department of Molecular Pharmacology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Fochtmann LJ; Department of Psychiatry, Department of Pharmacological Sciences, and Biomedical Informatics, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USA.
  • Gotlib D; Unaffiliated, Toronto, ON, Canada.
  • Holt A; Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
  • Insel TR; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Larsen JK; Department of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark.
  • Mago R; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Menkes DB; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
  • Meyer JM; Department of Psychiatry, UC San Diego School of Medicine, San Diego, CA, USA.
  • Nutt DJ; Department of Brain Sciences, Imperial College, London, UK.
  • Parker G; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia.
  • Rego MD; Yale Institute for Global Health, Yale School of Medicine, New Haven, CT, USA.
  • Richelson E; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
  • Ruhé HG; Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Sáiz-Ruiz J; Department of Psychiatry, Alcala University, Madrid, Spain.
  • Stahl SM; Department of Psychiatry and Neuroscience, University of California, Riverside, Riverside, CA, USA.
  • Steele T; Department of Psychiatry and Behavioral Sciences, University of South Carolina, Columbia, SC, USA.
  • Thase ME; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Ulrich S; Aristo Pharma GmbH, Berlin, Germany.
  • van Balkom AJLM; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Vieta E; Department of Psychiatry and Psychology, University of Barcelona Hospital Clinic, Barcelona, Spain.
  • Whyte I; Department of Clinical Toxicology and Pharmacology, University of Newcastle, Callaghan, NSW, Australia.
  • Young AH; Department of Psychological Medicine, King's College London, London, UK.
  • Gillman PK; PsychoTropical Research, QLD, Australia.
CNS Spectr ; : 1-14, 2022 Jul 15.
Article em En | MEDLINE | ID: mdl-35837681
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: CNS Spectr Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: CNS Spectr Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália